Total Funding
20
74
Total FundingPre-Seed raised
Growth Score
-1 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
169800
B4RNA develops a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method.
Carlos Palma: CEO
About the Company
B4RNA is a biotechnology company developing a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method. The company is in the preclinical trial phase and has received $1.25 million in funding, preparing for a pre-Series A round to expand clinical trials and launch operations in the United States.
